キッセイ薬品工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/09/04 | 3,535 | 3,550 | 3,465 | 3,550 | -5 | -0.1% | 90,700 |
2024/09/03 | 3,495 | 3,570 | 3,490 | 3,555 | +85 | +2.4% | 56,900 |
2024/09/02 | 3,490 | 3,540 | 3,470 | 3,470 | +10 | +0.3% | 52,800 |
2024/08/30 | 3,470 | 3,505 | 3,460 | 3,460 | -20 | -0.6% | 103,700 |
2024/08/29 | 3,465 | 3,510 | 3,460 | 3,480 | -30 | -0.9% | 30,300 |
2024/08/28 | 3,490 | 3,510 | 3,460 | 3,510 | +10 | +0.3% | 69,700 |
2024/08/27 | 3,455 | 3,510 | 3,455 | 3,500 | +55 | +1.6% | 47,400 |
2024/08/26 | 3,500 | 3,500 | 3,405 | 3,445 | -100 | -2.8% | 80,400 |
2024/08/23 | 3,540 | 3,590 | 3,530 | 3,545 | +30 | +0.9% | 76,900 |
2024/08/22 | 3,520 | 3,525 | 3,480 | 3,515 | -5 | -0.1% | 50,600 |
2024/08/21 | 3,505 | 3,560 | 3,495 | 3,520 | +10 | +0.3% | 86,800 |
2024/08/20 | 3,515 | 3,520 | 3,485 | 3,510 | +20 | +0.6% | 58,600 |
2024/08/19 | 3,500 | 3,510 | 3,470 | 3,490 | -30 | -0.9% | 40,000 |
2024/08/16 | 3,540 | 3,540 | 3,485 | 3,520 | +20 | +0.6% | 50,400 |
2024/08/15 | 3,520 | 3,520 | 3,480 | 3,500 | ±0 | ±0% | 35,900 |
2024/08/14 | 3,510 | 3,520 | 3,465 | 3,500 | -10 | -0.3% | 37,500 |
2024/08/13 | 3,450 | 3,515 | 3,445 | 3,510 | +40 | +1.2% | 42,700 |
2024/08/09 | 3,545 | 3,545 | 3,415 | 3,470 | ±0 | ±0% | 108,800 |
2024/08/08 | 3,395 | 3,495 | 3,395 | 3,470 | +70 | +2.1% | 118,200 |
2024/08/07 | 3,300 | 3,490 | 3,250 | 3,400 | +30 | +0.9% | 109,500 |
2024/08/06 | 3,360 | 3,455 | 3,300 | 3,370 | +150 | +4.7% | 125,400 |
2024/08/05 | 3,200 | 3,345 | 3,150 | 3,220 | -110 | -3.3% | 233,100 |
2024/08/02 | 3,420 | 3,420 | 3,265 | 3,330 | -160 | -4.6% | 118,000 |
2024/08/01 | 3,445 | 3,515 | 3,415 | 3,490 | -5 | -0.1% | 135,200 |
2024/07/31 | 3,400 | 3,500 | 3,400 | 3,495 | +205 | +6.2% | 182,000 |
2024/07/30 | 3,300 | 3,310 | 3,265 | 3,290 | -10 | -0.3% | 53,300 |
2024/07/29 | 3,260 | 3,330 | 3,260 | 3,300 | +50 | +1.5% | 47,900 |
2024/07/26 | 3,270 | 3,275 | 3,240 | 3,250 | -5 | -0.2% | 32,600 |
2024/07/25 | 3,250 | 3,285 | 3,235 | 3,255 | -30 | -0.9% | 81,900 |
2024/07/24 | 3,280 | 3,305 | 3,275 | 3,285 | +5 | +0.2% | 43,700 |
2024/07/23 | 3,265 | 3,285 | 3,255 | 3,280 | +40 | +1.2% | 36,600 |
2024/07/22 | 3,310 | 3,310 | 3,240 | 3,240 | -40 | -1.2% | 30,000 |
2024/07/19 | 3,320 | 3,320 | 3,265 | 3,280 | -40 | -1.2% | 21,200 |
2024/07/18 | 3,275 | 3,345 | 3,245 | 3,320 | +45 | +1.4% | 94,200 |
2024/07/17 | 3,260 | 3,290 | 3,245 | 3,275 | +15 | +0.5% | 52,600 |
2024/07/16 | 3,255 | 3,260 | 3,235 | 3,260 | +5 | +0.2% | 51,200 |
2024/07/12 | 3,200 | 3,260 | 3,200 | 3,255 | +5 | +0.2% | 60,600 |
2024/07/11 | 3,225 | 3,255 | 3,220 | 3,250 | +30 | +0.9% | 70,900 |
2024/07/10 | 3,230 | 3,230 | 3,200 | 3,220 | -10 | -0.3% | 43,700 |
2024/07/09 | 3,230 | 3,235 | 3,190 | 3,230 | +30 | +0.9% | 60,400 |
2024/07/08 | 3,190 | 3,225 | 3,190 | 3,200 | +10 | +0.3% | 48,100 |
2024/07/05 | 3,215 | 3,220 | 3,190 | 3,190 | -30 | -0.9% | 39,500 |
2024/07/04 | 3,245 | 3,260 | 3,200 | 3,220 | -10 | -0.3% | 43,600 |
2024/07/03 | 3,205 | 3,230 | 3,205 | 3,230 | +5 | +0.2% | 34,700 |
2024/07/02 | 3,215 | 3,235 | 3,205 | 3,225 | -5 | -0.2% | 61,900 |
2024/07/01 | 3,270 | 3,275 | 3,225 | 3,230 | -30 | -0.9% | 63,200 |
2024/06/28 | 3,240 | 3,260 | 3,230 | 3,260 | +15 | +0.5% | 66,700 |
2024/06/27 | 3,220 | 3,245 | 3,195 | 3,245 | ±0 | ±0% | 59,000 |
2024/06/26 | 3,220 | 3,245 | 3,210 | 3,245 | +20 | +0.6% | 61,000 |
2024/06/25 | 3,190 | 3,230 | 3,180 | 3,225 | +60 | +1.9% | 72,900 |
251~
300
件表示中 / 3783件
類似銘柄と比較する
現在ご覧いただいている「キッセイ薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
キッセイ薬 | 447,000円 | +3.6% | - | 2.68% | 15.06倍 | 0.89倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
日本新薬 | 329,300円 | +3.6% | -15.3% | 3.77% | 9.25倍 | 0.90倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
ペプチド | 173,400円 | +5.0% | +1.5% | 0.00% | 14.84倍 | 4.18倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
サンバイオ | 239,300円 | - | - | 0.00% | - | 110.84倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
科研薬 | 389,900円 | -6.4% | -71.8% | 4.87% | 43.42倍 | 0.97倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム